Showing results (11-20 of 59) with videos related to
Sort By:
Pageof 6
Journal of Medical Economics|July 8, 2010
Cost effectiveness of teriparatide and PTH(1-84) in the treatment of postmenopausal osteoporosisFredrik Borgström, Oskar Ström, Fernando Marin, et al.European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|November 6, 2010
Cost effectiveness of disc prosthesis versus lumbar fusion in patients with chronic low back pain: randomized controlled trial with 2-year follow-upPeter Fritzell, Svante Berg, Fredrik Borgström, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|December 30, 2006
The economic burden of depression in Sweden from 1997 to 2005Patrik Sobocki, Ingrid Lekander, Fredrik Borgström, et al.SAGE Open Medicine|June 17, 2024
Association between institutionalization by 4 months post-discharge walking capacity and lean body mass in elderly hip fracture patients: Evidence from a Swedish Registry Based StudySara Hallberg, Emma Söreskog, Fredrik Borgström, et al.Journal of Medical Economics|August 26, 2017
A health economic lifetime treatment pathway model for low back pain in SwedenGylfi Olafsson, Emma Jonsson, Peter Fritzell, et al.Bone|December 7, 2007
Cost effectiveness of hormone therapy in women at high risks of fracture in Sweden, the US and the UK--results based on the Women's Health Initiative randomised controlled trialIngrid Lekander, Fredrik Borgström, Oskar Ström, et al.Menopause International|February 25, 2009
Cost-effectiveness of hormone replacement therapy for menopausal symptoms in the UKIngrid Lekander, Fredrik Borgström, Oskar Ström, et al.Journal of Women'S Health (2002)|October 28, 2009
Cost-effectiveness of hormone therapy in the United StatesIngrid Lekander, Fredrik Borgström, Oskar Ström, et al.The Journal of Headache and Pain|August 14, 2020
Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and NorwayAmanda Hansson-Hedblom, Isabelle Axelsson, Lena Jacobson, et al.Bone|June 15, 2004
Cost effectiveness of alendronate for the treatment of male osteoporosis in SwedenFredrik Borgström, Olof Johnell, Bengt Jönsson, et al.Pageof 6